Yun Lin

Dr. Yun Lin


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Brain Research
Verified
Journal Article
Closed access
JZJiancheng Zhang
Jiancheng Zhang
YWYan Wu
Yan Wu
ZWZelin Weng
Zelin Weng
TZTing Zhou
Ting Zhou
TFTao Feng
Tao Feng
YLYun Lin
Yun Lin

29 June 2023 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
JMJiamin Ma
Jiamin Ma
FWFuquan Wang
Fuquan Wang
JWJingxu Wang
Jingxu Wang
PWPengcheng Wang
Pengcheng Wang
XDXiaoke Dou
Xiaoke Dou
YLYun Lin
Yun Lin
Purpose: This study aims to evaluate the effects of the intraoperative application of low-dose esketamine on postoperative neurocognitive dysfunction (PND) in elderly patients undergoing general anesthesia for gastrointestinal tumors. Methods: Sixty-eight elderly patients were randomly allocated to two groups: the esketamine group (group Es) (0.25 mg/kg loading, 0.125mg/kg/h infusion) and the control group (group C) (received normal saline). The primary outcome was the incidence of delayed neurocognitive recovery (DNR). The secondary outcomes were intraoperative blood loss, the total amount of fluid given during surgery, propofol and remifentanil consumption, cardiovascular adverse events, use of vasoactive drugs, operating and anesthesia time, the number of cases of sufentanil remedial analgesia, the incidence of postoperative delirium (POD), the intraoperative hemodynamics, bispectral index (BIS) value at 0, 1, 2 h after operation and numeric rating scale (NRS) pain scores within 3 d after surgery. Results: The incidence of DNR in group Es (16.13%) was lower than in group C (38.71%) (P < 0.05). The intraoperative remifentanil dosage and the number of cases of dopamine used in group Es were lower than in group C (P < 0.05). Compared with group C, DBP was higher at 3 min after intubation, and MAP was lower at 30 min after extubation in group Es (P< 0.05). The incidence of hypotension and tachycardia in group Es was lower than in group C (P < 0.05). The NRS pain score at 3 d after surgery in group Es was lower than in group C (P < 0.05). Conclusion: Low-dose esketamine infusion reduced to some extent the incidence of DNR in elderly patients undergoing general anesthesia for gastrointestinal tumors, improved intraoperative hemodynamics and BIS value, decreased the incidence of cardiovascular adverse events and the intraoperative consumption of opioids, and relieved postoperative pain.

1 August 2014 in Neuroscience
Verified
Journal Article
Closed access
JZJiancheng Zhang
Jiancheng Zhang
XMXiaobo Mao
Xiaobo Mao
TZTing Zhou
Ting Zhou
XCXiang Cheng
Xiang Cheng
YLYun Lin
Yun Lin

20 May 2016 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
JZJian-Cheng Zhang
Jian-Cheng Zhang
HXHang Xu
Hang Xu
YYYin Yuan
Yin Yuan
JCJia-Yi Chen
Jia-Yi Chen
YZYu-Jing Zhang
Yu-Jing Zhang
SYShiying Yuan
Shiying Yuan

21 April 2022 in Life Sciences
Verified
Journal Article
Closed access
YGYangyang Ge
Yangyang Ge
LWLi Wang
Li Wang
CWChenchen Wang
Chenchen Wang
JCJiayi Chen
Jiayi Chen
MDMaosha Dai
Maosha Dai
YLYun Lin
Yun Lin

7 November 2019 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
CYChengye Yao
Chengye Yao
YWYu Wang
Yu Wang
LWLijun Wang
Lijun Wang
YLYunning Liu
Yunning Liu
JLJiangmei Liu
Jiangmei Liu
MZMaigeng Zhou
Maigeng Zhou
Background: Headache has emerged as a global public health concern. However, little is known about the burden from headache disorders in China. The aim of this work was to quantify the spatial patterns and temporal trends of burden from headache disorders in China. Methods: Following the general analytic strategy used in the 2017 Global Burden of Disease study, we analyzed the prevalence and years lived with disability (YLDs) of headache and its main subcategories, including migraine and tension-type headache (TTH), by age, sex, year and 33 province-level administrative units in China from 1990 to 2017. Results: Almost 112.4 million individuals were estimated to have headache disorders in 1990 in China, which rose to 482.7 million in 2017. The all-age YLDs increased by 36.2% from 1990 to 2017. Migraine caused 5.5 million YLDs, much higher than TTH (1.1 million) in 2017. The age-standardized prevalence and YLDs rate of headache remained stable and high in 2017 compared with 1990, respectively. The proportion of total headache YLDs in all diseases increased from 1990 to 2017 by 5.4%. A female preponderance was observed for YLDs and the YLDs were mainly in people aged 20~54 years. Conclusions: Headache remains a huge health burden in China from 1990 to 2017, with prevalence and YLDs rates higher in eastern provinces than western provinces. The substantial increase in headache cases and YLDs represents an ongoing challenge in Chinese population. Our results can help shape and inform headache research and public policy throughout China, especially for females and middle-aged people.